CAS RN: 1216138-03-2
6-chloro-2,2-dimethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260701
250mg / 1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1216138-03-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1216138-03-2 / 6-chloro-2,2-dimethyl-3,4-dihydro-1,4-benzoxazine
Standard CAS: 1216138-03-2
Multi CAS: No
Basic Information
copy
CAS
1216138-03-2 copy
Multi CAS
No copy
Molecular Formula
C10H12ClNO copy
Molecular Weight
197.660000 copy
Exact Mass
197.060742 copy
SMILES
CC1(CNC2=C(O1)C=CC(=C2)Cl)C copy
InChI
InChI=1S/C10H12ClNO/c1-10(2)6-12-8-5-7(11)3-4-9(8)13-10/h3-5,12H,6H2,1-2H3 copy
InChIKey
MJQQQMHDPDCNLG-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.4 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
54.65 copy
TPSA
21.26 copy
LogP / Solubility
WLOGP
2.92 copy
MLOGP
2.57 copy
XLogP3
2.9 copy
Consensus LogP
2.8 copy
Log S (ESOL)
-3.25 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.29 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.37 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.85 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy